vs
Lantheus Holdings, Inc.（LNTH）とGIBRALTAR INDUSTRIES, INC.（ROCK）の財務データ比較。上の社名をクリックして会社を切り替えられます
Lantheus Holdings, Inc.の直近四半期売上が大きい（$406.8M vs $225.0M、GIBRALTAR INDUSTRIES, INC.の約1.8倍）。GIBRALTAR INDUSTRIES, INC.の前年同期比売上増加率が高い（24.9% vs 4.0%）。Lantheus Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$81.4M vs $26.2M）。過去8四半期でLantheus Holdings, Inc.の売上複合成長率が高い（4.9% vs -12.3%）
ランティウス・ホールディングスはグローバルな医療企業で、革新的な診断用造影剤や関連ソリューションの開発・製造・販売を事業の核としています。製品は腫瘍学、循環器学、泌尿器学などの分野に対応し、北米を中心に世界の主要市場で事業を展開しています。
ジブラルタル・インダストリーズ社は、特殊建築資材、インフラ関連製品、再生可能エネルギー向け製品の製造・販売を行う有力企業です。換気システム、屋根用付属品、太陽光発電設置架台、造園用品などを取り扱い、主に北米の住宅・商業建設、クリーンエネルギー市場向けにサービスを提供しています。
LNTH vs ROCK — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $406.8M | $225.0M |
| 純利益 | $54.1M | — |
| 粗利率 | 59.2% | 25.3% |
| 営業利益率 | 19.0% | 7.9% |
| 純利益率 | 13.3% | — |
| 売上前年比 | 4.0% | 24.9% |
| 純利益前年比 | 558.8% | — |
| EPS（希薄化後） | $0.86 | — |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $406.8M | $225.0M | ||
| Q3 25 | $384.0M | $310.9M | ||
| Q2 25 | $378.0M | $309.5M | ||
| Q1 25 | $372.8M | $290.0M | ||
| Q4 24 | $391.1M | $180.1M | ||
| Q3 24 | $378.7M | $277.1M | ||
| Q2 24 | $394.1M | $273.6M | ||
| Q1 24 | $370.0M | $292.5M |
| Q4 25 | $54.1M | — | ||
| Q3 25 | $27.8M | $-89.1M | ||
| Q2 25 | $78.8M | $26.0M | ||
| Q1 25 | $72.9M | $21.1M | ||
| Q4 24 | $-11.8M | — | ||
| Q3 24 | $131.1M | $34.0M | ||
| Q2 24 | $62.1M | $32.2M | ||
| Q1 24 | $131.1M | $24.9M |
| Q4 25 | 59.2% | 25.3% | ||
| Q3 25 | 57.9% | 26.6% | ||
| Q2 25 | 63.8% | 28.4% | ||
| Q1 25 | 63.8% | 26.8% | ||
| Q4 24 | 63.5% | 29.0% | ||
| Q3 24 | 63.9% | 29.4% | ||
| Q2 24 | 64.9% | 30.5% | ||
| Q1 24 | 65.4% | 28.9% |
| Q4 25 | 19.0% | 7.9% | ||
| Q3 25 | 11.4% | 12.8% | ||
| Q2 25 | 23.3% | 12.8% | ||
| Q1 25 | 27.4% | 8.8% | ||
| Q4 24 | 29.1% | 13.3% | ||
| Q3 24 | 35.3% | 15.6% | ||
| Q2 24 | 26.1% | 14.9% | ||
| Q1 24 | 28.8% | 10.8% |
| Q4 25 | 13.3% | — | ||
| Q3 25 | 7.2% | -28.6% | ||
| Q2 25 | 20.8% | 8.4% | ||
| Q1 25 | 19.6% | 7.3% | ||
| Q4 24 | -3.0% | — | ||
| Q3 24 | 34.6% | 12.3% | ||
| Q2 24 | 15.8% | 11.8% | ||
| Q1 24 | 35.4% | 8.5% |
| Q4 25 | $0.86 | — | ||
| Q3 25 | $0.41 | $-2.98 | ||
| Q2 25 | $1.12 | $0.87 | ||
| Q1 25 | $1.02 | — | ||
| Q4 24 | $-0.18 | — | ||
| Q3 24 | $1.79 | $1.11 | ||
| Q2 24 | $0.88 | $1.05 | ||
| Q1 24 | $1.87 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $359.1M | $115.7M |
| 総負債低いほど良い | $568.7M | $0 |
| 株主資本純資産 | $1.1B | $950.4M |
| 総資産 | $2.2B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.52× | 0.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $359.1M | $115.7M | ||
| Q3 25 | $382.0M | $89.4M | ||
| Q2 25 | $695.6M | $43.3M | ||
| Q1 25 | $938.5M | $25.1M | ||
| Q4 24 | $912.8M | $269.5M | ||
| Q3 24 | $866.4M | $228.9M | ||
| Q2 24 | $757.0M | $179.1M | ||
| Q1 24 | $718.3M | $146.7M |
| Q4 25 | $568.7M | $0 | ||
| Q3 25 | $567.9M | $0 | ||
| Q2 25 | $566.8M | $0 | ||
| Q1 25 | $566.1M | $0 | ||
| Q4 24 | $565.3M | $0 | ||
| Q3 24 | $613.0K | $0 | ||
| Q2 24 | $563.2M | $0 | ||
| Q1 24 | $562.5M | $0 |
| Q4 25 | $1.1B | $950.4M | ||
| Q3 25 | $1.1B | $951.8M | ||
| Q2 25 | $1.2B | $1.0B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.0B | $975.7M | ||
| Q1 24 | $945.5M | $940.2M |
| Q4 25 | $2.2B | $1.4B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $2.0B | $1.4B | ||
| Q2 24 | $1.9B | $1.4B | ||
| Q1 24 | $1.8B | $1.3B |
| Q4 25 | 0.52× | 0.00× | ||
| Q3 25 | 0.51× | 0.00× | ||
| Q2 25 | 0.49× | 0.00× | ||
| Q1 25 | 0.49× | 0.00× | ||
| Q4 24 | 0.52× | 0.00× | ||
| Q3 24 | 0.00× | 0.00× | ||
| Q2 24 | 0.55× | 0.00× | ||
| Q1 24 | 0.59× | 0.00× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $90.2M | $35.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $81.4M | $26.2M |
| FCFマージンFCF / 売上 | 20.0% | 11.7% |
| 設備投資強度設備投資 / 売上 | 2.2% | 4.1% |
| キャッシュ転換率営業CF / 純利益 | 1.67× | — |
| 直近12ヶ月FCF直近4四半期 | $354.1M | $120.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $90.2M | $35.5M | ||
| Q3 25 | $105.3M | $73.0M | ||
| Q2 25 | $87.1M | $44.9M | ||
| Q1 25 | $107.6M | $13.7M | ||
| Q4 24 | $157.7M | $19.9M | ||
| Q3 24 | $175.1M | $64.7M | ||
| Q2 24 | $84.7M | $36.5M | ||
| Q1 24 | $127.2M | $53.2M |
| Q4 25 | $81.4M | $26.2M | ||
| Q3 25 | $94.7M | $64.8M | ||
| Q2 25 | $79.1M | $27.3M | ||
| Q1 25 | $98.8M | $2.3M | ||
| Q4 24 | $141.4M | $14.1M | ||
| Q3 24 | $159.3M | $60.5M | ||
| Q2 24 | $73.5M | $33.5M | ||
| Q1 24 | $119.0M | $48.8M |
| Q4 25 | 20.0% | 11.7% | ||
| Q3 25 | 24.7% | 20.8% | ||
| Q2 25 | 20.9% | 8.8% | ||
| Q1 25 | 26.5% | 0.8% | ||
| Q4 24 | 36.1% | 7.8% | ||
| Q3 24 | 42.0% | 21.8% | ||
| Q2 24 | 18.7% | 12.2% | ||
| Q1 24 | 32.2% | 16.7% |
| Q4 25 | 2.2% | 4.1% | ||
| Q3 25 | 2.8% | 2.6% | ||
| Q2 25 | 2.1% | 5.7% | ||
| Q1 25 | 2.3% | 3.9% | ||
| Q4 24 | 4.2% | 3.3% | ||
| Q3 24 | 4.2% | 1.5% | ||
| Q2 24 | 2.8% | 1.1% | ||
| Q1 24 | 2.2% | 1.5% |
| Q4 25 | 1.67× | — | ||
| Q3 25 | 3.79× | — | ||
| Q2 25 | 1.11× | 1.73× | ||
| Q1 25 | 1.47× | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.34× | 1.90× | ||
| Q2 24 | 1.36× | 1.13× | ||
| Q1 24 | 0.97× | 2.13× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
